146 related articles for article (PubMed ID: 22433274)
1. Off-target cannabinoid effects mediated by GPR55.
Henstridge CM
Pharmacology; 2012; 89(3-4):179-87. PubMed ID: 22433274
[TBL] [Abstract][Full Text] [Related]
2. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
Hu G; Ren G; Shi Y
Oncogene; 2011 Jan; 30(2):139-41. PubMed ID: 21057532
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the novel cannabinoid receptor - GPR55 - during rat fetoplacental development.
Fonseca BM; Teixeira NA; Almada M; Taylor AH; Konje JC; Correia-da-Silva G
Placenta; 2011 Jun; 32(6):462-9. PubMed ID: 21497900
[TBL] [Abstract][Full Text] [Related]
4. In silico patent searching reveals a new cannabinoid receptor.
Baker D; Pryce G; Davies WL; Hiley CR
Trends Pharmacol Sci; 2006 Jan; 27(1):1-4. PubMed ID: 16318877
[TBL] [Abstract][Full Text] [Related]
5. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
Yang H; Zhou J; Lehmann C
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
[TBL] [Abstract][Full Text] [Related]
6. The enigmatic pharmacology of GPR55.
Ross RA
Trends Pharmacol Sci; 2009 Mar; 30(3):156-63. PubMed ID: 19233486
[TBL] [Abstract][Full Text] [Related]
7. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK.
Andradas C; Caffarel MM; Pérez-Gómez E; Salazar M; Lorente M; Velasco G; Guzmán M; Sánchez C
Oncogene; 2011 Jan; 30(2):245-52. PubMed ID: 20818416
[TBL] [Abstract][Full Text] [Related]
8. Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.
Henstridge CM; Balenga NA; Kargl J; Andradas C; Brown AJ; Irving A; Sanchez C; Waldhoer M
Mol Endocrinol; 2011 Nov; 25(11):1835-48. PubMed ID: 21964594
[TBL] [Abstract][Full Text] [Related]
9. Advances Towards The Discovery of GPR55 Ligands.
Morales P; Jagerovic N
Curr Med Chem; 2016; 23(20):2087-100. PubMed ID: 27109575
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55.
Balenga NA; Henstridge CM; Kargl J; Waldhoer M
Adv Pharmacol; 2011; 62():251-77. PubMed ID: 21907912
[TBL] [Abstract][Full Text] [Related]
11. Identification of GPR55 as a lysophosphatidylinositol receptor.
Oka S; Nakajima K; Yamashita A; Kishimoto S; Sugiura T
Biochem Biophys Res Commun; 2007 Nov; 362(4):928-34. PubMed ID: 17765871
[TBL] [Abstract][Full Text] [Related]
12. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
Zhao P; Abood ME
Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
[TBL] [Abstract][Full Text] [Related]
13. Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding.
Ramírez-Orozco RE; García-Ruiz R; Morales P; Villalón CM; Villafán-Bernal JR; Marichal-Cancino BA
Curr Neuropharmacol; 2019; 17(10):947-960. PubMed ID: 31146657
[TBL] [Abstract][Full Text] [Related]
14. GPR55: a new promising target for metabolism?
Tudurí E; Imbernon M; Hernández-Bautista RJ; Tojo M; Fernø J; Diéguez C; Nogueiras R
J Mol Endocrinol; 2017 Apr; 58(3):R191-R202. PubMed ID: 28196832
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
Morales P; Lago-Fernandez A; Hurst DP; Sotudeh N; Brailoiu E; Reggio PH; Abood ME; Jagerovic N
J Med Chem; 2020 Dec; 63(23):14216-14227. PubMed ID: 32914978
[TBL] [Abstract][Full Text] [Related]
16. What is the natural ligand of GPR55?
Okuno T; Yokomizo T
J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983
[TBL] [Abstract][Full Text] [Related]
17. A potential role for GPR55 in gastrointestinal functions.
Schicho R; Storr M
Curr Opin Pharmacol; 2012 Dec; 12(6):653-8. PubMed ID: 23063456
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
19. GPR55 as a new cannabinoid receptor: still a long way to prove it.
Petitet F; Donlan M; Michel A
Chem Biol Drug Des; 2006 Mar; 67(3):252-3. PubMed ID: 16611220
[No Abstract] [Full Text] [Related]
20. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
